EHSI · Elite Health Systems Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40M | - | $0 | $0 | $0 | - | $0 | $0 | $0 | - |
| Cost of Revenue | $0 | - | - | - | - | - | - | - | - | - |
| Gross Profit | $117.0K | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $1.42M | - | $1.17M | $445.0K | $427.0K | - | $387.0K | $437.0K | $476.0K | - |
| Total Operating Expenses | $1.42M | - | $1.17M | $445.0K | $476.0K | - | $151.0K | $437.0K | $476.0K | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | ($1.30M) | - | ($1.17M) | ($445.0K) | ($427.0K) | - | ($387.0K) | ($437.0K) | ($476.0K) | - |
| Interest Expense | - | - | - | - | - | - | $1.0K | $0 | $1.0K | - |
| Income Tax | - | - | $0 | $0 | - | - | - | - | ($163.0K) | - |
| Net Income | ($1.29M) | - | ($1.16M) | ($441.0K) | ($424.0K) | - | ($290.0K) | ($435.0K) | ($312.0K) | - |
| EPS - Basic | ($0.05) | - | ($0.05) | ($0.02) | ($0.02) | - | ($0.02) | ($0.03) | ($0.03) | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | ($0.03) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.60M | $3.76M | $3.97M | $3.12M | $3.70M | $4.03M | $3.17M | $2.19M | $1.75M | $466.0K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | $0 |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $3.27M | $4.48M | $4.27M | $3.16M | $3.73M | $4.25M | $3.19M | $2.24M | $1.81M | $527.0K |
| Total Assets | $5.43M | $6.66M | $5.31M | $3.98M | $4.32M | $4.32M | $3.80M | $3.03M | $2.60M | $1.32M |
| Current Liabilities | $1.36M | $1.34M | $270.0K | $167.0K | $51.0K | $94.0K | $93.0K | $976.0K | $2.20M | $607.0K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $1.37M | $1.35M | $291.0K | $197.0K | $91.0K | $143.0K | $143.0K | $1.03M | $2.27M | $676.0K |
| Stockholders' Equity | $4.06M | $5.31M | $5.02M | $333.0K | $4.18M | $4.18M | $3.66M | $2.00M | $333.0K | $645.0K |
| Retained Earnings | ($13.54M) | ($12.25M) | ($6.47M) | ($5.31M) | ($4.87M) | ($4.45M) | ($3.42M) | ($3.14M) | ($2.70M) | ($2.39M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($1.26M) | - | - | - | ($297.0K) | - | - | - | ($461.0K) | - |
| Investing Cash Flow | $0 | - | - | - | ($515.0K) | - | - | - | $0 | - |
| Financing Cash Flow | $100.0K | - | - | - | $474.0K | - | - | - | $1.75M | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 8.4% | - | - | - | - | - | - | - | - | - |
| Operating margin | -92.8% | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | -92.6% | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 101.2% | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -23.8% | - | -21.9% | -11.1% | -9.8% | - | -7.6% | -14.3% | -12.0% | - |
| Return on equity | -31.9% | - | -23.1% | -132.4% | -10.1% | - | -7.9% | -21.8% | -93.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.40 | 3.35 | 15.83 | 18.93 | 73.14 | 45.20 | 34.31 | 2.30 | 0.82 | 0.87 |
| Quick ratio | 2.40 | 3.35 | 15.83 | 18.93 | 73.14 | 45.20 | 34.31 | 2.30 | 0.82 | 0.87 |
| Cash ratio | 1.91 | 2.80 | 14.70 | 18.69 | 72.47 | 42.91 | 34.12 | 2.25 | 0.79 | 0.77 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | -387.0x | - | -476.0x | - |
| Equity multiplier | 1.34 | 1.25 | 1.06 | 11.96 | 1.03 | 1.03 | 1.04 | 1.52 | 7.81 | 2.05 |
| Liabilities / Assets | 0.25 | 0.20 | 0.05 | 0.05 | 0.02 | 0.03 | 0.04 | 0.34 | 0.87 | 0.51 |
| Efficiency | ||||||||||
| Asset turnover | 0.26 | - | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | 28.6x | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | 5.7% | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -204.0% | - | -201.0% | -1.8% | 10.3% | - | -156.3% | -80.6% | -266.2% | - |
| Net income growth (YoY) | -205.2% | - | -300.3% | -1.4% | -35.9% | - | -128.3% | -0.2% | -188.9% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | -200.0% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -2.8% | 27.2% | 37.1% | -83.3% | 1154.7% | 547.8% | 542.3% | 186.2% | -70.6% | -47.9% |
Peer comparison
Same SIC group: Services-Specialty Outpatient Facilities, NEC
Comparing Elite Health Systems Inc. against the 5 most active filers in the same SIC group.